Education
About Us
Working with TipRanks
Follow Us
Erich Platzer Insider Profile
4 Followers
Erich Platzer, Director at Vivoryon Therapeutics AG, holds 355.41K shares in Vivoryon Therapeutics AG (Ticker: GB:0R3M). Most recently, Erich Platzer Bought €123,809 shares of Vivoryon Therapeutics AG on Apr 05, 2022 for an estimated value of 1.30M.
Erich Platzer Vivoryon Therapeutics AG (0R3M)Director
Vivoryon Therapeutics AG (0R3M)
Director
Ranked #55,842 out of 100,956 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-3.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Erich Platzer holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 05, 2022 - Apr 05, 2023
Return:+34.00%
The most profitable trade made by Erich Platzer
Erich Platzer's Trading History
List of latest transactions for each holding click on a transaction to see Erich Platzer's performance on stock
You May Also Like
Erich Platzer insider profile FAQ
What is the percentage of profitable transactions made by Erich Platzer?
The percentage of profitable transactions made by Erich Platzer is 25%.
What is the average return per transaction made by Erich Platzer?
The average return per transaction made by Erich Platzer is -3.30%.
What stocks does Erich Platzer hold?
Erich Platzer holds: GB:0R3M stocks.
What was Erich Platzer’s latest transaction?
Erich Platzer latest transaction was an Informative Buy of €1.30M.
What was Erich Platzer's most profitable transaction?
Erich Platzer’s most profitable transaction was an Informative Buy of GB:0R3M stock on April 5, 2022. The return on the trade was 34.00%.
What is Erich Platzer's role in Vivoryon Therapeutics AG?
Erich Platzer's role in Vivoryon Therapeutics AG is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.